Isarna Therapeutics is a biotech company developing selective TGF-β inhibitors to fight cancer and to effectively treat ophthalmic and fibrotic diseases.
Isarna Therapeutics is a biotech company developing selective TGF-β inhibitors to fight cancer and to effectively treat ophthalmic and fibrotic diseases.